fgf-23 protein, human
Recombinant proteinexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2011 (NCT02813642)
Timeline
No events for the selected filters.
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- fgf-23 protein, human
- fgf23 protein, human
- fgf-23 protein, mouse
- fgf23 protein, mouse
- fibroblast growth factor 23
- fibroblast growth factor 23
- fibroblast growth factor 23, human
- fibroblast growth factor 23, mouse
- phosphatonin, mouse
- tumor-derived hypophophatemia inducing factor, human
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02808572 | N/A | Mar 1, 2013 | CHU Lapeyronie, University of Montpellier |
| NCT02813642 | N/A | Dec 1, 2011 | CHU Lapeyronie, University of Montpellier |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| CHU Lapeyronie | Academic/Hospital | 2 | 0 | 1 | 2011 |
| University of Montpellier | Academic/Hospital | 2 | 2 | 1 | 2011 |
2 organizations
Page 1 / 1